| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | +3.19% | -5.75% | +8.95% | +5.82% | — |
| 14d | 4 | +50.00% | -0.52% | -2.73% | +2.22% | -8.22% | — |
| 30d | 4 | +50.00% | +27.84% | +1.69% | +26.15% | -6.04% | — |
| 60d | 4 | +75.00% | +68.77% | +7.68% | +61.09% | +6.67% | — |
| 90d | 4 | +100.00% | +77.11% | +7.14% | +69.97% | +43.16% | — |
| 180d | 4(1 pending) | +100.00% | +164.03% | +12.24% | +151.79% | +2.92% | — |
| 1y | 4(1 pending) | +100.00% | +172.13% | +26.80% | +145.32% | +132.26% | — |
| 2y | 4(1 pending) | +100.00% | +159.77% | +51.82% | +107.95% | +170.94% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE Corporate Secretary | 135,690 | $4.23 | $574.0K | 231,042 | May 7, 2026 | May 11, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE Corporate Secretary | 76,147 | $4.18 | $318.3K | 366,732 | May 5, 2026 | May 7, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE Chief Legal Officer | 40,102 | $4.17 | $167.3K | 442,879 | Mar 10, 2026 | Mar 11, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 50,000 | $4.29 | $214.5K | 50,000 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 482,981 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE Chief Legal Officer | 10,658 | $2.65 | $28.2K | 402,981 | Mar 9, 2025 | Mar 11, 2025 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 82,500 | — | — | 82,500 | Mar 7, 2025 | Apr 13, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE Chief Legal Officer | 9,592 | $2.65 | $25.4K | 413,639 | Mar 7, 2025 | Mar 11, 2025 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Mar 7, 2025 | Mar 11, 2025 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 110,000 | — | — | 423,231 | Mar 7, 2025 | Mar 11, 2025 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE SVP, General Counsel | 10,530 | $4.88 | $51.4K | 313,231 | Mar 9, 2024 | Mar 12, 2024 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 67,500 | — | — | 67,500 | Mar 7, 2024 | Mar 11, 2024 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 135,000 | — | — | 323,761 | Mar 7, 2024 | Mar 11, 2024 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Aug 9, 2023 | Aug 9, 2023 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | May 5, 2023 | May 9, 2023 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 188,761 | Mar 9, 2023 | Mar 9, 2023 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Nov 4, 2022 | Nov 8, 2022 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASE General Counsel | 13,761 | $0.96 | $13.2K | 38,761 | Jun 8, 2022 | Jun 10, 2022 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASE General Counsel | 13,761 | $0.13 | $1.8K | 13,761 | Jun 8, 2022 | Jun 10, 2022 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 160,000 | — | — | 160,000 | Mar 10, 2022 | Mar 14, 2022 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Mar 11, 2021 | Mar 15, 2021 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASE SVP, General Counsel | 14,000 | $1.54 | $21.6K | 25,000 | Mar 16, 2020 | Mar 18, 2020 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Mar 16, 2020 | Mar 18, 2020 ↗ | View → |